{"id":46380,"topic":"peptides","source":"AFR","title":"Peptide industry eyes multibillion-dollar payday under Trump - AFR","url":"https://www.afr.com/world/north-america/peptide-industry-eyes-multi-billion-dollar-payday-under-trump-20260726-p60ioe","url_hash":"4df155dc5fab9f53c3c6df7554723421beb97959","author":"","summary":"<a href=\"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNNUdfeTZfQ2NLelY5SjYtYldISmpIOVloemlHWnFqZ215aVh3eGhoOFdJZ2hwbXlNU0hDaDVwS3pWQ19saFJPS1NwVmI4RktrUkNwSi1DSlRUcGJjU3dHanVVTzR1YjlPRElqcDVkOW5jeGtDQUI3T3BPQ1RSbVA0eW9NNzVUV1RKdkR0LXNiSFdrV3pUYTRIZ2R3T0JKVW9DM3haMFNmdDJ2U3VUYV9WeFFwRWJEbkRI?oc=5\" target=\"_blank\">Peptide industry eyes multibillion-dollar payday under Trump</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AFR</font>","content":"New York | Businesses tied to Robert F. Kennedy Jr’s Make America Healthy Again movement are poised to benefit from a regulatory overhaul in Washington, as companies aligned with his agenda emerge as its earliest winners.\nAt a two-day meeting at the US Food and Drug Administration last week, a Kennedy-backed advisory panel voted to broaden public access to a handful of drugs known as peptides, despite the agency’s scientific staff advising against it.\nFinancial Times","image_url":"https://static.ffx.io/images/$zoom_0.2515%2C$multiply_3%2C$ratio_1.777778%2C$width_1059%2C$x_0%2C$y_338/t_crop_custom/c_scale%2Cw_800%2Cq_88%2Cf_jpg/t_afr_no_label_no_age_social_wm/3200ca46aa61ec757a2c50fe8feb83e0f315c41b","lang":"en","published_at":"2026-07-26T06:59:00+00:00","fetched_at":"2026-07-26T09:15:10+00:00","status":"read","starred":0,"extract_state":"ok","summary_auto":"Kennedy Jr’s Make America Healthy Again movement are poised to benefit from a regulatory overhaul in Washington, as companies aligned with his agenda emerge as its earliest winners. At a two-day meeting at the US Food and Drug Administration last week, a Kennedy-backed advisory panel voted to broaden public access to a handful of drugs known as peptides, despite the agency’s scientific staff advising against it.","cluster_id":null,"extract_retries":0,"extract_error":null,"contract_version":"news_item.v1","format_contract_version":"news_item_formats.v1","dedup_url":"https://www.afr.com/world/north-america/peptide-industry-eyes-multi-billion-dollar-payday-under-trump-20260726-p60ioe","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 471 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":471,"summary_length":415,"usable_text_length":471,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":471,"summary_length":415}},"news_item":{"id":46380,"canonical_url":"https://www.afr.com/world/north-america/peptide-industry-eyes-multi-billion-dollar-payday-under-trump-20260726-p60ioe","source_url":"https://www.afr.com/world/north-america/peptide-industry-eyes-multi-billion-dollar-payday-under-trump-20260726-p60ioe","title":"Peptide industry eyes multibillion-dollar payday under Trump - AFR","source_name":"AFR","author":null,"published_at":"2026-07-26T06:59:00+00:00","locale":"en","topic":"peptides","tags":[],"rss_summary":"<a href=\"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNNUdfeTZfQ2NLelY5SjYtYldISmpIOVloemlHWnFqZ215aVh3eGhoOFdJZ2hwbXlNU0hDaDVwS3pWQ19saFJPS1NwVmI4RktrUkNwSi1DSlRUcGJjU3dHanVVTzR1YjlPRElqcDVkOW5jeGtDQUI3T3BPQ1RSbVA0eW9NNzVUV1RKdkR0LXNiSFdrV3pUYTRIZ2R3T0JKVW9DM3haMFNmdDJ2U3VUYV9WeFFwRWJEbkRI?oc=5\" target=\"_blank\">Peptide industry eyes multibillion-dollar payday under Trump</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AFR</font>","full_text":"New York | Businesses tied to Robert F. Kennedy Jr’s Make America Healthy Again movement are poised to benefit from a regulatory overhaul in Washington, as companies aligned with his agenda emerge as its earliest winners.\nAt a two-day meeting at the US Food and Drug Administration last week, a Kennedy-backed advisory panel voted to broaden public access to a handful of drugs known as peptides, despite the agency’s scientific staff advising against it.\nFinancial Times","excerpt":"Kennedy Jr’s Make America Healthy Again movement are poised to benefit from a regulatory overhaul in Washington, as companies aligned with his agenda emerge as its earliest winners. At a two-day meeting at the US Food and Drug Administration last week, a Kennedy-backed advisory panel voted to broaden public access to a handful of drugs known as peptides, despite the agency’s scientific staff advising against it.","extraction":{"state":"ok","confidence":0.9,"error":null,"explanation":"High confidence: full text extraction produced 471 characters.","diagnostics_url":"/api/diagnose?url=https%3A//www.afr.com/world/north-america/peptide-industry-eyes-multi-billion-dollar-payday-under-trump-20260726-p60ioe","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 471 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":471,"summary_length":415,"usable_text_length":471,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":471,"summary_length":415}}},"display_formats":["compact","card","full","digest_section","json"]},"daily_stack_record":{"title":"Peptide industry eyes multibillion-dollar payday under Trump - AFR","url":"https://www.afr.com/world/north-america/peptide-industry-eyes-multi-billion-dollar-payday-under-trump-20260726-p60ioe","summary":"Kennedy Jr’s Make America Healthy Again movement are poised to benefit from a regulatory overhaul in Washington, as companies aligned with his agenda emerge as its earliest winners. At a two-day meeting at the US Food and Drug Administration last week, a Kennedy-backed advisory panel voted to broaden public access to a handful of drugs known as peptides, despite the agency’s scientific staff advising against it.","source":"AFR","date":"2026-07-26T06:59:00+00:00","content":"New York | Businesses tied to Robert F. Kennedy Jr’s Make America Healthy Again movement are poised to benefit from a regulatory overhaul in Washington, as companies aligned with his agenda emerge as its earliest winners.\nAt a two-day meeting at the US Food and Drug Administration last week, a Kennedy-backed advisory panel voted to broaden public access to a handful of drugs known as peptides, despite the agency’s scientific staff advising against it.\nFinancial Times","confidence":0.9,"diagnostics_url":"/api/diagnose?url=https%3A//www.afr.com/world/north-america/peptide-industry-eyes-multi-billion-dollar-payday-under-trump-20260726-p60ioe","quality_bucket":"high","failure_kind":"none","retryable":false,"quality_reason":"High confidence: full text extraction produced 471 characters.","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 471 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":471,"summary_length":415,"usable_text_length":471,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":471,"summary_length":415}},"tags":[]},"fallback_formats":["markdown","json","html"],"actions":{"read":"/item/46380","export_markdown":"/api/items/46380/export?format=markdown","export_json":"/api/items/46380/export?format=json","diagnose":"/api/diagnose?url=https%3A//www.afr.com/world/north-america/peptide-industry-eyes-multi-billion-dollar-payday-under-trump-20260726-p60ioe"},"formats":{"full":{"id":46380,"title":"Peptide industry eyes multibillion-dollar payday under Trump - AFR","url":"https://www.afr.com/world/north-america/peptide-industry-eyes-multi-billion-dollar-payday-under-trump-20260726-p60ioe","source":"AFR","author":null,"published_at":"2026-07-26T06:59:00+00:00","locale":"en","topic":"peptides","tags":[],"excerpt":"Kennedy Jr’s Make America Healthy Again movement are poised to benefit from a regulatory overhaul in Washington, as companies aligned with his agenda emerge as its earliest winners. At a two-day meeting at the US Food and Drug Administration last week, a Kennedy-backed advisory panel voted to broaden public access to a handful of drugs known as peptides, despite the agency’s scientific staff advising against it.","full_text":"New York | Businesses tied to Robert F. Kennedy Jr’s Make America Healthy Again movement are poised to benefit from a regulatory overhaul in Washington, as companies aligned with his agenda emerge as its earliest winners.\nAt a two-day meeting at the US Food and Drug Administration last week, a Kennedy-backed advisory panel voted to broaden public access to a handful of drugs known as peptides, despite the agency’s scientific staff advising against it.\nFinancial Times","reading_time_min":1,"extraction":{"state":"ok","confidence":0.9,"error":null,"explanation":"High confidence: full text extraction produced 471 characters.","diagnostics_url":"/api/diagnose?url=https%3A//www.afr.com/world/north-america/peptide-industry-eyes-multi-billion-dollar-payday-under-trump-20260726-p60ioe","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 471 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":471,"summary_length":415,"usable_text_length":471,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":471,"summary_length":415}}},"quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 471 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":471,"summary_length":415,"usable_text_length":471,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":471,"summary_length":415}},"actions":{"read":"/item/46380","export_markdown":"/api/items/46380/export?format=markdown","export_json":"/api/items/46380/export?format=json","diagnose":"/api/diagnose?url=https%3A//www.afr.com/world/north-america/peptide-industry-eyes-multi-billion-dollar-payday-under-trump-20260726-p60ioe"}},"digest":{"id":46380,"title":"Peptide industry eyes multibillion-dollar payday under Trump - AFR","url":"https://www.afr.com/world/north-america/peptide-industry-eyes-multi-billion-dollar-payday-under-trump-20260726-p60ioe","source":"AFR","topic":"peptides","published_at":"2026-07-26T06:59:00+00:00","excerpt":"Kennedy Jr’s Make America Healthy Again movement are poised to benefit from a regulatory overhaul in Washington, as companies aligned with his agenda emerge as its earliest winners. At a two-day meeting at the US Food and Drug Administration last week, a Kennedy-backed advisory…","quality_bucket":"high","quality_reason":"High confidence: full text extraction produced 471 characters.","reading_time_min":1,"cluster_id":null},"card":{"display_title":"Peptide industry eyes multibillion-dollar payday under Trump - AFR","subtitle":"AFR · 2026-07-26","summary":"Kennedy Jr’s Make America Healthy Again movement are poised to benefit from a regulatory overhaul in Washington, as companies aligned with his agenda emerge as its earliest winners. At a two-day meeting at the US Food…","badges":["quality:high"],"links":{"read":"/item/46380","original":"https://www.afr.com/world/north-america/peptide-industry-eyes-multi-billion-dollar-payday-under-trump-20260726-p60ioe","diagnose":"/api/diagnose?url=https%3A//www.afr.com/world/north-america/peptide-industry-eyes-multi-billion-dollar-payday-under-trump-20260726-p60ioe"},"quality_warning":null},"export":{"title":"Peptide industry eyes multibillion-dollar payday under Trump - AFR","url":"https://www.afr.com/world/north-america/peptide-industry-eyes-multi-billion-dollar-payday-under-trump-20260726-p60ioe","summary":"Kennedy Jr’s Make America Healthy Again movement are poised to benefit from a regulatory overhaul in Washington, as companies aligned with his agenda emerge as its earliest winners. At a two-day meeting at the US Food and Drug Administration last week, a Kennedy-backed advisory panel voted to broaden public access to a handful of drugs known as peptides, despite the agency’s scientific staff advising against it.","source":"AFR","date":"2026-07-26T06:59:00+00:00","content":"New York | Businesses tied to Robert F. Kennedy Jr’s Make America Healthy Again movement are poised to benefit from a regulatory overhaul in Washington, as companies aligned with his agenda emerge as its earliest winners.\nAt a two-day meeting at the US Food and Drug Administration last week, a Kennedy-backed advisory panel voted to broaden public access to a handful of drugs known as peptides, despite the agency’s scientific staff advising against it.\nFinancial Times","confidence":0.9,"diagnostics_url":"/api/diagnose?url=https%3A//www.afr.com/world/north-america/peptide-industry-eyes-multi-billion-dollar-payday-under-trump-20260726-p60ioe","quality_bucket":"high","failure_kind":"none","retryable":false,"quality_reason":"High confidence: full text extraction produced 471 characters.","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 471 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":471,"summary_length":415,"usable_text_length":471,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":471,"summary_length":415}},"tags":[],"format_contract_version":"news_item_formats.v1"}}}